Ausgabe 2-3/2014
Special Issue: Clinical and Basic Science Aspects of Prostate Cancer
Inhalt (31 Artikel)
Mouse models of prostate cancer: picking the best model for the question
Magdalena M. Grabowska, David J. DeGraff, Xiuping Yu, Ren Jie Jin, Zhenbang Chen, Alexander D. Borowsky, Robert J. Matusik
AR function in promoting metastatic prostate cancer
Michael A. Augello, Robert B. Den, Karen E. Knudsen
Histone H2A.Z deregulation in prostate cancer. Cause or effect?
Deanna Dryhurst, Juan Ausió
The role of epithelial plasticity in prostate cancer dissemination and treatment resistance
Rhonda L. Bitting, Daneen Schaeffer, Jason A. Somarelli, Mariano A. Garcia-Blanco, Andrew J. Armstrong
Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy
Lei Chang, Peter H. Graham, Jingli Hao, Joseph Bucci, Paul J. Cozzi, John H. Kearsley, Yong Li
Integrating new discoveries into the “vicious cycle” paradigm of prostate to bone metastases
Leah M. Cook, Gemma Shay, Arturo Aruajo, Conor C. Lynch
Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases
Aimalie L. Hardaway, Mackenzie K. Herroon, Erandi Rajagurubandara, Izabela Podgorski
Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapeutics
Deborah Mukherji, Aurelius Omlin, Carmel Pezaro, Ali Shamseddine, Johann de Bono
Novel drugs targeting the androgen receptor pathway in prostate cancer
Joaquin Mateo, Alan Smith, Michael Ong, Johann S. de Bono
Growth factor and signaling pathways and their relevance to prostate cancer therapeutics
Jocelyn L. Wozney, Emmanuel S. Antonarakis
Src signaling pathways in prostate cancer
Andreas Varkaris, Anastasia D. Katsiampoura, John C. Araujo, Gary E. Gallick, Paul G. Corn
Bone-targeting agents in prostate cancer
Daniel L. Suzman, Sosipatros A. Boikos, Michael A. Carducci
Recent progress on nutraceutical research in prostate cancer
Yiwei Li, Aamir Ahmad, Dejuan Kong, Bin Bao, Fazlul H. Sarkar
Immunotherapy for prostate cancer: recent developments and future challenges
Michael T. Schweizer, Charles G. Drake
Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel
Adriana Amaro, Alessia Isabella Esposito, Anna Gallina, Matthias Nees, Giovanna Angelini, Adriana Albini, Ulrich Pfeffer
Emerging technology: applications of Raman spectroscopy for prostate cancer
Rachel E. Kast, Stephanie C. Tucker, Kevin Killian, Micaela Trexler, Kenneth V. Honn, Gregory W. Auner
The developing story of Sprouty and cancer
Samar Masoumi-Moghaddam, Afshin Amini, David Lawson Morris
Mimicking breast cancer-induced bone metastasis in vivo: current transplantation models and advanced humanized strategies
Laure Thibaudeau, Verena M. Quent, Boris M. Holzapfel, Anna V. Taubenberger, Melanie Straub, Dietmar W. Hutmacher
Immune regulation of therapy-resistant niches: emerging targets for improving anticancer drug responses
Masahisa Jinushi
Circulating tumour cells—a bona fide cause of metastatic cancer
N. J. Caixeiro, N. Kienzle, S. H. Lim, K. J. Spring, A. Tognela, K. F. Scott, P. de Souza, T. M. Becker
Advances in genomic characterization of circulating tumor cells
Mark Jesus M. Magbanua, John W. Park
Clinical models and biochemical predictors of VTE in lung cancer
M. Roselli, S. Riondino, S. Mariotti, F. La Farina, P. Ferroni, F. Guadagni
Emerging strategies to overcome resistance to endocrine therapy for breast cancer
M. Firdos Ziauddin, Dong Hua, Shou-Ching Tang
Antibody-based imaging strategies for cancer
Jason M. Warram, Esther de Boer, Anna G. Sorace, Thomas K. Chung, Hyunki Kim, Rick G. Pleijhuis, Gooitzen M. van Dam, Eben L. Rosenthal
Extracellular acidity, a “reappreciated” trait of tumor environment driving malignancy: perspectives in diagnosis and therapy
Silvia Peppicelli, Francesca Bianchini, Lido Calorini